Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M; REIPI/GEIH Study Groups.

J Antimicrob Chemother. 2013 Jun;68(6):1423-30. doi: 10.1093/jac/dkt016. Epub 2013 Feb 12.

PMID:
23404193
2.

Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Molina J, Lopez-Medrano F, Ruiz E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MA, Benito N, Rodriguez-Baño J, Espejo E, Pujol M; REIPI/GEIH Study Groups.

Clin Microbiol Infect. 2013 Nov;19(11):1049-57. doi: 10.1111/1469-0691.12108. Epub 2013 Jan 17.

3.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565
4.

Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, Kim EC, Oh MD, Choe KW.

J Antimicrob Chemother. 2004 Aug;54(2):489-97. Epub 2004 Jul 14.

PMID:
15254028
5.

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28.

PMID:
20511366
6.

Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.

Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, Samra Z, Paghis D, Bishara J, Leibovici L.

J Antimicrob Chemother. 2010 Dec;65(12):2658-65. doi: 10.1093/jac/dkq373. Epub 2010 Oct 14. Review.

PMID:
20947620
7.

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.

Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, Viscoli C, Tumbarello M.

Clin Microbiol Infect. 2012 Sep;18(9):862-9. doi: 10.1111/j.1469-0691.2011.03679.x. Epub 2011 Oct 14.

8.

Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martín-Gandul C, López-Medrano F, de Gopegui ER, Ramón Blanco J, García-Pardo G, Calbo E, Horcajada JP, Granados A, Jover-Sáenz A, Dueñas C, Pujol M; REIPI/GEIM Study Groups.

Clin Microbiol Infect. 2014 Apr;20(4):361-7. doi: 10.1111/1469-0691.12330. Epub 2013 Aug 28.

9.

Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.

Chang HJ, Hsu PC, Yang CC, Siu LK, Kuo AJ, Chia JH, Wu TL, Huang CT, Lee MH.

J Antimicrob Chemother. 2012 Mar;67(3):736-41. doi: 10.1093/jac/dkr531. Epub 2011 Dec 14.

PMID:
22169187
10.

Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.

Naves KS, Vaz da Trindade N, Gontijo Filho PP.

Rev Soc Bras Med Trop. 2012 Mar-Apr;45(2):189-93.

11.

Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.

Forstner C, Dungl C, Tobudic S, Mitteregger D, Lagler H, Burgmann H.

Clin Microbiol Infect. 2013 Jul;19(7):E291-7. doi: 10.1111/1469-0691.12169. Epub 2013 Mar 13.

12.

Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.

Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN.

BMC Infect Dis. 2011 Oct 31;11:298. doi: 10.1186/1471-2334-11-298.

13.

Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Marchaim D, Kaye KS, Fowler VG, Anderson DJ, Chawla V, Golan Y, Karchmer AW, Carmeli Y.

Clin Microbiol Infect. 2010 Jun;16(6):747-52. doi: 10.1111/j.1469-0691.2009.02934.x. Epub 2009 Sep 11.

14.

Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients.

Tumbarello M, de Gaetano Donati K, Tacconelli E, Citton R, Spanu T, Leone F, Fadda G, Cauda R.

J Antimicrob Chemother. 2002 Sep;50(3):375-82.

PMID:
12205062
15.

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.

Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC.

J Antimicrob Chemother. 2011 Oct;66(10):2386-92. doi: 10.1093/jac/dkr301. Epub 2011 Jul 20.

PMID:
21775337
16.

Impact of acute kidney injury on mortality and medical costs in patients with meticillin-resistant Staphylococcus aureus bacteraemia: a retrospective, multicentre observational study.

Joo EJ, Peck KR, Ha YE, Kim YS, Song YG, Lee SS, Ryu SY, Moon C, Lee CS, Park KH.

J Hosp Infect. 2013 Apr;83(4):300-6. doi: 10.1016/j.jhin.2012.12.008. Epub 2013 Jan 29.

PMID:
23369468
17.

Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand.

Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR, Coombs GW, Murray RJ, Howden B, Johnson PD, Dowling K; Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis.

Med J Aust. 2009 Oct 5;191(7):368-73.

PMID:
19807625
18.

Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan.

Liao CH, Chen SY, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2008 Oct;32(4):326-32. doi: 10.1016/j.ijantimicag.2008.04.011. Epub 2008 Jul 9.

PMID:
18617372
19.

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.

Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667.

PMID:
18171250
20.

A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.

Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):322-32.

Supplemental Content

Support Center